Labo Euromedis (STU:61R) Margin of Safety % (DCF FCF Based): N/A (As of Jul. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:61R Labo Euromedis STU:61R
68 GF Score
Price €4.88
GF Value €4.39
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Labo Euromedis Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Labo Euromedis's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

STU:61R vs MCK, CAH, COR: Margin of Safety % (DCF FCF Based) Comparison

For the Medical Distribution subindustry, Labo Euromedis's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Labo Euromedis Margin of Safety % (DCF FCF Based) vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Labo Euromedis's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Labo Euromedis's Margin of Safety % (DCF FCF Based) falls into.


STU:61R
68GF Score
Labo Euromedis STU:61R
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Labo Euromedis (STU:61R) Overvalued in 2026?

Based on GuruFocus' analysis, Labo Euromedis stock appears to be overvalued. The current stock price of €4.88 is trading 11.2% above its estimated GF Value™ of €4.39. GuruFocus considers Labo Euromedis to be Modestly Overvalued.

Key valuation signals for STU:61R:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: €4.39 vs. price of €4.88 (11.2% above fair value)
  • GF Score™: 68/100 with 6 warning signs

No single metric tells the full story. See the STU:61R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Labo Euromedis Business Description

Other Exchanges 0I0L:UKALEMG:France
Address ZI de la Tuilerie, Neuilly-sous-Clermont, FRA, 60290
Labo Euromedis is engaged in medical devices. It is engaged in the design, manufacture, rental and export of medical and surgical equipment and products.
68GF Score

Get the complete analysis for STU:61R

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.88
Price
€4.39
GF Value